407 related articles for article (PubMed ID: 15609302)
1. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database.
Carvalho AL; Nishimoto IN; Califano JA; Kowalski LP
Int J Cancer; 2005 May; 114(5):806-16. PubMed ID: 15609302
[TBL] [Abstract][Full Text] [Related]
2. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis.
Pulte D; Brenner H
Oncologist; 2010; 15(9):994-1001. PubMed ID: 20798198
[TBL] [Abstract][Full Text] [Related]
3. Population-based analysis of the human development index and risk factors for head and neck cancer.
Chien IA; Hsu YC; Tsai CH; Cheng SP
Head Neck; 2024 Apr; 46(4):889-895. PubMed ID: 38213093
[TBL] [Abstract][Full Text] [Related]
4. Patient delay and its clinical significance among head and neck cancer patients in Hungary.
Dános K; Horváth A; Halász J; Tamás L; Polony G
Pathol Oncol Res; 2023; 29():1611206. PubMed ID: 37674645
[No Abstract] [Full Text] [Related]
5. Subsite-specific trends in mid- and long-term survival for head and neck cancer patients in Japan: A population-based study.
Tsuge H; Kawakita D; Taniyama Y; Oze I; Koyanagi YN; Hori M; Nakata K; Sugiyama H; Miyashiro I; Oki I; Nishino Y; Katanoda K; Ito Y; Shibata A; Matsuda T; Iwasaki S; Matsuo K; Ito H
Cancer Sci; 2024 Feb; 115(2):623-634. PubMed ID: 37994633
[TBL] [Abstract][Full Text] [Related]
6. Long-term Cancer Survival Trends by Updated Summary Stage.
Forjaz G; Ries L; Devasia TP; Flynn G; Ruhl J; Mariotto AB
Cancer Epidemiol Biomarkers Prev; 2023 Nov; 32(11):1508-1517. PubMed ID: 37623930
[TBL] [Abstract][Full Text] [Related]
7. Stage shift and relative survival for head and neck cancer during the 2020 COVID-19 pandemic: a population-based study of temporal trends.
Peacock HM; De Gendt C; Silversmit G; Nuyts S; Casselman J; Machiels JP; Giusti F; van Gool B; Vander Poorten V; Van Eycken L
Front Oncol; 2023; 13():1253968. PubMed ID: 37799467
[TBL] [Abstract][Full Text] [Related]
8. Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure.
Botta L; Matsuda T; Charvat H; Chiang CJ; Lee WC; van Gestel AJ; Martin F; Geleijnse G; Cellamare M; Bonfarnuzzo S; Marcos-Gragera R; Guevara M; Mousavi M; Craig S; Rodrigues J; Rubió-Casadevall J; Licitra L; Cavalieri S; Resteghini C; Gatta G; Trama A;
Front Oncol; 2023; 13():1219111. PubMed ID: 37781187
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of head and neck cancer in the United States.
Davies L; Welch HG
Otolaryngol Head Neck Surg; 2006 Sep; 135(3):451-7. PubMed ID: 16949981
[TBL] [Abstract][Full Text] [Related]
10. Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment.
Marur S; Forastiere AA
Mayo Clin Proc; 2016 Mar; 91(3):386-96. PubMed ID: 26944243
[TBL] [Abstract][Full Text] [Related]
11. International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site.
Simard EP; Torre LA; Jemal A
Oral Oncol; 2014 May; 50(5):387-403. PubMed ID: 24530208
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological Trends of Head and Neck Cancer in the United States: A SEER Population Study.
Mourad M; Jetmore T; Jategaonkar AA; Moubayed S; Moshier E; Urken ML
J Oral Maxillofac Surg; 2017 Dec; 75(12):2562-2572. PubMed ID: 28618252
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus and rising oropharyngeal cancer incidence in the United States.
Chaturvedi AK; Engels EA; Pfeiffer RM; Hernandez BY; Xiao W; Kim E; Jiang B; Goodman MT; Sibug-Saber M; Cozen W; Liu L; Lynch CF; Wentzensen N; Jordan RC; Altekruse S; Anderson WF; Rosenberg PS; Gillison ML
J Clin Oncol; 2011 Nov; 29(32):4294-301. PubMed ID: 21969503
[TBL] [Abstract][Full Text] [Related]
14. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?
Sturgis EM; Cinciripini PM
Cancer; 2007 Oct; 110(7):1429-35. PubMed ID: 17724670
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive genomic characterization of head and neck squamous cell carcinomas.
Cancer Genome Atlas Network
Nature; 2015 Jan; 517(7536):576-82. PubMed ID: 25631445
[TBL] [Abstract][Full Text] [Related]
16. Improved survival using intensity-modulated radiation therapy in head and neck cancers: a SEER-Medicare analysis.
Beadle BM; Liao KP; Elting LS; Buchholz TA; Ang KK; Garden AS; Guadagnolo BA
Cancer; 2014 Mar; 120(5):702-10. PubMed ID: 24421077
[TBL] [Abstract][Full Text] [Related]
17. Five-year survival rates and time trends of laryngeal cancer in the US population.
Cosetti M; Yu GP; Schantz SP
Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):370-9. PubMed ID: 18427002
[TBL] [Abstract][Full Text] [Related]
18. Head and neck cancer: changing epidemiology, diagnosis, and treatment.
Marur S; Forastiere AA
Mayo Clin Proc; 2008 Apr; 83(4):489-501. PubMed ID: 18380996
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.
Pignon JP; le Maître A; Maillard E; Bourhis J;
Radiother Oncol; 2009 Jul; 92(1):4-14. PubMed ID: 19446902
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512).
Trotti A; Zhang Q; Bentzen SM; Emami B; Hammond ME; Jones CU; Morrison WH; Sagar SM; Ridge JA; Fu KK; Ang KK
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):958-963. PubMed ID: 25035199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
